|
| 1 | PHM40704 | THERAPEUTICS IV (INFECTIOUS DISEASE, ONCOLOGY & RESPIRATORY DISEASES) |
| 2 | PHM41102 | TRADITIONAL & COMPLEMENTARY MEDICINE |
| 3 | PHM40203 | CLINICAL PHARMACOKINETICS & PHARMACOGENOMICS |
| 4 | PHM40402 | MEDICATION REVIEW & COUNSELLING |
| 5 | PHM30103 | RESEARCH METHODOLOGY |
| 6 | PHM40103 | THERAPEUTICS II (ENDOCRINOLOGICAL, GUT DISORDERS) |
| 7 | PHM40303 | THERAPEUTICS III (NEUROLOGY, PSYCHIATRY, DERMATOLOGY & PAIN) |
| 8 | PHM41006 | COMMUNITY PHARMACY CLERKSHIP |
| 9 | PHM31405 | PHARMACY RESEARCH |
| 10 | PHM31204 | THERAPEUTICS I (CVS & GIT) |
| 11 | PHM40704 | THERAPEUTICS IV (INFECTIOUS DISEASE, ONCOLOGY & RESPIRATORY DISEASES) |
| 12 | PHM40203 | CLINICAL PHARMACOKINETICS & PHARMACOGENOMICS |
| 13 | PHM40402 | MEDICATION REVIEW & COUNSELLING |
| 14 | PHM30103 | RESEARCH METHODOLOGY |
| 15 | PHM40103 | THERAPEUTICS II (ENDOCRINOLOGICAL, GUT DISORDERS) |
| 16 | PHM40303 | THERAPEUTICS III (NEUROLOGY, PSYCHIATRY, DERMATOLOGY & PAIN) |
| 17 | PHM21102 | CENTRAL NERVOUS SYSTEM PHARMACOTHERAPEUTICS |
| 18 | PHM41006 | COMMUNITY PHARMACY CLERKSHIP |
| 19 | PHM31405 | PHARMACY RESEARCH |
| 20 | PHM31204 | THERAPEUTICS I (CVS & GIT) |
| 21 | PHM40704 | THERAPEUTICS IV (INFECTIOUS DISEASE, ONCOLOGY & RESPIRATORY DISEASES) |
| 22 | PHM40203 | CLINICAL PHARMACOKINETICS & PHARMACOGENOMICS |
| 23 | PHM30703 | ENDOCRINE, REPRODUCTIVE & GENITO-URINARY SYSTEM PHARMACOTHERAPEUTICS |
| 24 | PHM30103 | RESEARCH METHODOLOGY |
| 25 | PHM40103 | THERAPEUTICS II (ENDOCRINOLOGICAL, GUT DISORDERS) |
| 26 | PHM40303 | THERAPEUTICS III (NEUROLOGY, PSYCHIATRY, DERMATOLOGY & PAIN) |
| 27 | PHM31103 | ANTIMICROBIAL & CYTOTOXIC PHARMACEUTICALS |
| 28 | PHM31405 | PHARMACY RESEARCH |
| 29 | PHM31204 | THERAPEUTICS I (CVS & GIT) |
| 30 | PHM40704 | THERAPEUTICS IV (INFECTIOUS DISEASE, ONCOLOGY & RESPIRATORY DISEASES) |
| 31 | PHM40203 | CLINICAL PHARMACOKINETICS & PHARMACOGENOMICS |
| 32 | PHM30703 | ENDOCRINE, REPRODUCTIVE & GENITO-URINARY SYSTEM PHARMACOTHERAPEUTICS |
| 33 | PHM10103 | ORGANIC & INORGANIC CHEMISTRY |
| 34 | PHM40103 | THERAPEUTICS II (ENDOCRINOLOGICAL, GUT DISORDERS) |
| 35 | PHM31103 | ANTIMICROBIAL & CYTOTOXIC PHARMACEUTICALS |
| 36 | PHM21302 | BIOPHARMACEUTICS AND PHARMACOKINETICS |
| 37 | PHM20903 | DOSAGE FORM DESIGN II (SOLID PHARMACEUTICALS) |
| 38 | PHM31204 | THERAPEUTICS I (CVS & GIT) |
| 39 | PHM30703 | ENDOCRINE, REPRODUCTIVE & GENITO-URINARY SYSTEM PHARMACOTHERAPEUTICS |
| 40 | PHM30303 | FORMULATION, CHARACTERISATION & PACKAGING |
| 41 | PHM30502 | MANUFACTURING PHARMACY |
| 42 | PHM30802 | SUBSTANCE USE & ABUSE |